Cerebras Systems, a pioneer in high performance artificial intelligence (AI) computing, and AbbVie, a global biopharmaceutical company, announced a landmark achievement in AbbVie’s AI work.
Life science companies gather and generate large amounts of data; however, this data often remains widely untouched, ungoverned, unstructured, and stored in disparate silos. In 2022 and beyond, life sciences organizations that uncover how to make use of their expansive data will be positioned to distinguish themselves competitively.
Lifebit Biotech Ltd. announced the beginning of a long-term partnership with Boehringer Ingelheim to utilize Natural Language Processing (NLP) and Artificial Intelligence (AI) for the detection and early reporting of global disease outbreaks using real-world data harvested from scientific publications and other open sources.
The COVID-19 pandemic has redefined what it means and what it takes to be a healthcare provider in a time of crisis. In a new study from McCann Health, the data from the original 2016 Truth About Doctors study was re-examined and updated, highlighting the need to focus on prioritizing the health and wellbeing of physicians to ultimately help foster a healthier public.
As large pharmaceutical companies increasingly look to outsource aspects of drug discovery and development to external collaborators, the ability to identify the right partnership candidates before competitors has become critical.
In this webinar, Dr. Benjamin Darbro and Alyssa Hahn will discuss how their organization is using Natural Language Processing to transform unstructured source data into clinical and research decision support insights.
